Attached files
| file | filename |
|---|---|
| S-1/A - FORM S-1/A - MyMD Pharmaceuticals, Inc. | v356720_s1a.htm |
| EX-23.1 - EXHIBIT 23.1 - MyMD Pharmaceuticals, Inc. | v356720_ex23-1.htm |
| EX-10.10 - EXHIBIT 10.10 - MyMD Pharmaceuticals, Inc. | v356720_ex10-10.htm |
| EX-10.11 - EXHIBIT 10.11 - MyMD Pharmaceuticals, Inc. | v356720_ex10-11.htm |
| EX-10.12 - EXHIBIT 10.12 - MyMD Pharmaceuticals, Inc. | v356720_ex10-12.htm |
Consent of Director Nominee
In accordance with Rule 438 under the Securities Act of 1933, as amended (the “Securities Act”), the undersigned hereby consents to being named as a director nominee and impending board member of Akers Biosciences, Inc. (the “Company”) in the Company’s Registration Statement on Form S-1 (Registration No. 333-190456) and in all amendments (including post-effective amendments) thereto.
Dated: October 2, 2013
| /s/ Brandon Knox |